Olivier Christophe: Colocalization of Factor X with Amyloid Light-Chain Deposits
Olivier Christophe, Director of Research at Inserm, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haematologica, adding:
“I’m pleased to share our new publication in Haematologica:
‘Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patients’
In this study, we provide immunofluorescence evidence showing colocalization of factor X with amyloid light-chain deposits in tissues from patients with AL amyloidosis, supporting the concept of direct FX sequestration by amyloid deposits.
Importantly, FX deposition was observed even in one patient with normal circulating FX activity, raising interesting questions about the potential role of FX as a biomarker of residual amyloid burden and organ recovery.
We hope this work will encourage clinicians to systematically monitor FX levels in patients with AL amyloidosis.
Indeed, FX monitoring during treatment may provide complementary prognostic information, help assess bleeding risk — particularly before invasive procedures — and better reflect the persistence of residual amyloid deposits beyond hematologic remission.
This work formed an important part of the thesis of Sénadé Atsou and is dedicated to the memory of Frank Bridoux, whose vision and commitment to amyloidosis research made this work possible.
Many thanks to all co-authors from HITh lab Inserm and collaborators from CHU de Poitiers who contributed to this multidisciplinary effort.”
Title: Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patients
Authors: Sénadé Atsou, Alexia Rinsant, Caterina Casari, Peter J Lenting, Vincent Javaugue, Estelle Desport, Laurent Macchi, Cécile V. Denis, Frank Bridoux, Olivier D. Christophe
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 22, 2026, 17:27Masudah Paleker: Suboptimal Warfarin Control in South Africa
-
Aug 22, 2026, 17:26Maxime Dely: Sickle Cell Disease – Behind Every Exchange, There Is a Donor
-
Aug 22, 2026, 17:05Mostafa Elshazly: Managing Anticoagulant-Related Bleeding in Clinical Practice
-
Aug 22, 2026, 17:01Cesarovic Nikola: FDA Data Reanalysis Raises Questions About Moderna’s mFLUSIVA Risk-Benefit Profile
-
Aug 22, 2026, 16:38Andreas Linkermann: Decoding the Chain Reaction of Ferroptotic Cell Death
-
Aug 22, 2026, 16:33Nicolas Hulscher: FDA Data Reanalysis Raises Alarms Over Moderna’s MFLUSIVA
-
Aug 22, 2026, 16:19Moti Haim: Transforming AF Care in the Elderly
-
Aug 22, 2026, 16:12Hussam Hammoud: A Slap Is Not “Just a Slap” When the Patient Has Hemophilia
-
Aug 22, 2026, 15:53Howard Smith: Publix’s GreenWise Organic Frozen Berries Have E. coli Contamination